🟢 Boston Scientific is trading 4.2% up today as a recovery bounce despite broader healthcare weakness

Boston Scientific is trading 4.2% up today at $44.84, staging a recovery bounce despite a broader decline in the healthcare sector.

• There are no fresh company-specific headlines, earnings, or FDA decisions dated July 16, 2026, to explain the move.
• The gain appears to be a technical rebound for the well-liked medtech name following a period of recent selling pressure.
• The stock's performance is particularly notable as it comes against a backdrop of broad weakness across healthcare equities.